Skip to content
Company Analysis

Akanda Corp. AKAN

A comprehensive view of key metrics, scores, and financial health for Akanda Corp.

Overview of Akanda Corp.

AKAN NCM
Healthcare Drug Manufacturers - Specialty & Generic Micro Cap
Akanda Corp. (AKAN), is a Micro Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $0.82, about 0.0% overvalued vs fair value, -96.6% 1Y return, ranked 972/1110 in sector.
$0.82
-2.96%
As of March 13, 2026
Previous close • Vol 90d: 151.4%
Market Cap
$1.73M
Enterprise Value
$-407,126
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Akanda Corp..

Top Beats
No strong beats yet

Quick Facts

Website https://www.akandacorp.com
HQ Toronto, ON
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-2
$-2
$-2
Current: $0.82

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$836.7K
97.5%%
Gross Profit
$208.4K
251.2%%
Operating Income (EBIT)
$-3.2M
11.8%%
Operating Cash Flow
$-4.0M
-165.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Revenue Growth (YoY)
+1.0%
Fair

Modest revenue growth

Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Akanda Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
15
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
7
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 88% Coverage
Trade-Off Triangle Visualization A ternary plot showing AKAN's balance between Growth (66.0%), Profitability (6.4%), and Safety (27.6%). Growth 66% Safety 28% Profitability 6%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

92th percentile vs peers
93
Key Signals
Rev Growth YoY 97.5% 92p Revenue CAGR 3Y 1.72 96p EPS Growth YoY 99.8% 88p
Strengths
  • Growth performance in top 20% of peers (percentile: 92)
  • Rev Growth Yoy in top 20% of peers (97.5%, 92th percentile)
  • Revenue Cagr 3Y in top 20% of peers (1.72, 96th percentile)
  • Eps Growth Yoy in top 20% of peers (99.8%, 88th percentile)
Risks

No significant risks identified for this axis.

Profitability

8th percentile vs peers
9
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

38th percentile vs peers
39
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Akanda Corp..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-1.58
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info